india glp 1 Indian Patient Groups Push for GLP-1 Diabetes Drugs After WHO Recognition, ETPharma livfitty

Patients with pre-existing diabetic retinopathy should be aware that rapid improvement in blood glucose control with semaglutide may temporarily worsen retinopathy

CHICAGO Patients with diabetes who used GLP-1 receptor agonists demonstrated lower risks for certain rheumatic diseases, including rheumatoid arthritis and gout, according to data presented at ACR Convergence 2025

Weekly doses, when used, may range from 600 to 1200 mg under supervision, but such use is not FDA-approved and must be approached cautiously

Nayak warned that using diabetes medication solely for weight loss without supervision is dangerous